# Toll Biotech Co., Ltd.(Beijing)

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/toll-biotech-co-ltd-beijing

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.toll-biotech.com
- Total disclosed funding: $16M
- Latest round: Series A (Sep 15, 2025)
- Investors on record: 8

## About

Established in 2020 and based in Beijing, China, Toll Biotech Co., Ltd.(Beijing) is a technology company that provides research and development of new drugs for autoimmune diseases. The founder of the company, Professor Yin Hang, is the Associate Dean, School of Pharmacy, Tsinghua University. The company also was awarded as Zhongguancun High-Tech Enterprises.

The company has launched three technology platforms which are new drug development platform, preclinical development platform and clinical development platform. The company's product pipeline can be applied to rheumatoid arthritis, lupus erythematosus, viral infections, Parkinson's, etc. The company has cooperation with Tsinghua University, Peking University, Chinese Academy of Sciences and etc.

The company will focus on the development of new drugs for autoimmune diseases and the construction of the company's research and development center and drug development platform to further strengthen the company's research and development strength and expand its pipeline.

## Funding rounds

- Series A, Sep 15, 2025 — Qihang Capital, Guangzhou City Development Investment
- Series A, Mar 9, 2022, $16M — Casstar Capital, Lapam Capital, Zhongguancun Co-Innovative Fund Management, Yuanhui Investment
- Angel, Mar 10, 2021 — Lotus Lake Capital, Zhongguancun Development Group

## Investors

- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Angel
- Zhongguancun Development Group — Angel
- Casstar Capital (https://capitalatlas.ai/funds/casstar-capital) — Series A
- Lapam Capital (https://capitalatlas.ai/funds/lapam-capital) — Series A
- Zhongguancun Co-Innovative Fund Management (https://capitalatlas.ai/funds/zhongguancun-co-innovative-fund-management) — Series A
- Yuanhui Investment — Series A
- Qihang Capital (https://capitalatlas.ai/funds/qihang-capital) — Series A
- Guangzhou City Development Investment — Series A